Epidemiology, pathophysiology, and initial management of chronic immune thrombocytopenic purpura

American Journal of Health-System Pharmacy

Volumn 66, Issue 2 SUPPL., 2009, Pages

  Pruemer, Jane ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Corticosteroids; Diagnosis; Epidemiology; Globulin immune; Immune thrombocytopenic purpura; Protocols; Serums

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; RHESUS D ANTIBODY; THROMBOPOIETIN;

CHRONIC DISEASE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPLENECTOMY; SYMPTOM;

EID: 58449109676     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080490     Document Type: Conference Paper

References (18)

1. McMillan R. The pathogenesis of chronic immune thrombocytopenic purpura. Semin Hematol. 2007; 44(4 suppl 5):S3-S11.
2. Harrington WJ, Minnich V, Hollingworth W et al. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med. 1951;38:1-10.
3. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002; 346:995-1008.
4. Psaila B, Bussel JB. Immune thrombocytopenic purpura. Hematol Oncol Clin North Am. 2007; 21:743-59, vii.
5. Platelet Disorder Support Association. www.pdsa.org/itp-information/ index.html (accessed 2008 Sept 4).
6. Cohen YC, Djulbegovic B, Shamai-Lubovitz O et al. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med. 2000; 160:1630-8.
7. Tarantino M. Recent advances in the treatment of childhood immune thrombocytopenic purpura. Semin Hematol. 2006; 43(3 suppl 5):S11-S17.
8. Bussel J. Treatment of immune thrombocytopenic purpura in adults. Semin Hematol. 2006; 43(3 suppl 5):S3-S10.
9. George JN, Woolf SH, Raskob GE et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996; 88:3-40.
10. Doan CA, Bouroncle BA, Wiseman BK. Idiopathic and secondary thrombocytopenic purpura: clinical study and evaluation of 381 cases over a period of 28 years. Ann Intern Med. 1960; 53:861-76.
11. British Committee for Standards in Haematology GHTF. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003; 120:574-96.
12. Godeau B, Chevret S, Varet B et al. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet. 2002; 359:23-9.
13. Duhem C, Dicato MA, Ries F. Side-effects of intravenous immune globulins. Clin Exp Immunol. 1994; 97(suppl 1):79-83.
14. Bierling P, Godeau B. Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on. Vox Sang. 2004; 86:8-14.
15. Godeau B, Caulier MT, Decuypere L et al. Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w. Br J Haematol. 1999; 107:716-9.
16. Scaradavou A, Woo B, Woloski BM et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood. 1997; 89:2689-700.
17. Kojouri K, Vesely SK, Terrell DR et al. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004; 104:2623-34.
18. Schwartz J, Leber MD, Gillis S et al. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol. 2003; 72:94-8.